alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
|    |                                                                                 |
|----|---------------------------------------------------------------------------------|
| 1. | I have reviewed this annual report on Form 10-K/A of Noble Corporation plc; and |

|    |                                                                                                                                                                                                                                                                                                            |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |

|                                                                                                                                  |
|----------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                  |
| March 13, 2017                                                                                                                   |
|                                                                                                                             |
| /s/ David W. Williams                                                                                                            |
| David W. Williams                                                                                                                |
| Chairman, President and Chief Executive Officerof Noble Corporation plc, a company registered under the laws ofEngland and Wales |
H. Res. 87 

In the House of Representatives, U. S., 

February 1, 2023. 

Resolved, That the following named Members be, and are 

hereby, elected to the following standing committees of the 

House of Representatives: 

COMMITTEE ON EDUCATION AND THE WORKFORCE: Mr. 

Grijalva, Mr. Courtney, Mr. Sablan, Ms. Wilson of Florida, 

Ms. Bonamici, Mr. Takano, Ms. Adams, Mr. DeSaulnier, Mr. 

Norcross, Ms. Jayapal, Ms. Wild, Mrs. McBath, Mrs. Hayes, 

Ms. Omar, Ms. Stevens, Ms. Leger Fernandez, Ms. Manning, 

Mr. Mrvan, Mr. Bowman. 

COMMITTEE ON FOREIGN AFFAIRS: Mr. Sherman, Mr. 

Connolly, Mr. Keating, Mr. Cicilline, Mr. Bera, Mr. Castro of 

Texas, Ms. Titus, Mr. Lieu, Ms. Wild, Mr. Phillips, Ms. 

Omar, Mr. Allred, Ms. Spanberger, Ms. Houlahan, Mr. Kim 

of New Jersey, Ms. Jacobs, Ms. Manning, Mrs. CherfilusMcCormick, Mr. Stanton, Ms. Dean of Pennsylvania, Mr. 

Moskowitz, Mr. Jackson of Illinois, Ms. Kamlager-Dove. 

COMMITTEE ON SCIENCE, SPACE, AND TECHNOLOGY: 

Ms. Bonamici, Mr. Bera, Ms. Stevens, Ms. Sherrill, Mr. Bow-
2 

•HRES 87 EH 

man, Ms. Ross, Mr. Sorensen, Ms. Salinas, Mrs. Foushee, 

Mr. Mullin, Mr. Jackson of North Carolina, Mrs. Sykes, Mr. 

Frost, Ms. Caraveo, Ms. Lee of Pennsylvania, Mr. Lieu, Mr. 

Casten. 

COMMITTEE ON SMALL BUSINESS: Mr. Golden of Maine, 

Mr. Mfume, Mr. Phillips, Mr. Landsman, Ms. Perez, Mr. 

Thanedar, Mr. McGarvey, Ms. Scholten, Ms. Chu, Ms. Davids of Kansas, Mr. Pappas. 

Attest: 

Clerk.
**Exhibit 32.3**

 

**CERTIFICATION OF**

**PRINCIPAL ACCOUNTING OFFICER**

**OF TRM CORPORATION**

**PURSUANT TO 18 U.S.C. SECTION 1350**

 

Pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, I, Rebecca J. Demy, Principal Accounting Officer of TRM Corporation (the“Company”), hereby certify that the accompanying Quarterly Report of theCompany on Form 10-Q for the quarter ended March 31, 2004 (the “Report”), fullycomplies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934 and that the information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 

 
| Dated:  May  12, 2004 | /s/ Rebecca J. Demy           |   |
|----------------------------|-------------------------------|--------|
|                       | Rebecca J. Demy               |
|                       | Principal Accounting  Officer |

 

1

----
IV 

118TH CONGRESS 

1ST SESSION H. RES. 824 

Supporting the goals and ideals of ‘‘National Veterans Small Business Week’’. 

IN THE HOUSE OF REPRESENTATIVES 

OCTOBER 30, 2023 

Mr. CROW (for himself, Mr. FITZPATRICK, Mr. SCHNEIDER, Mrs. KIM of California, Ms. KUSTER, Ms. SALAZAR, Ms. DEAN of Pennsylvania, Ms. LEE

of Nevada, Ms. TITUS, Mrs. DINGELL, Mr. MOONEY, Mr. VARGAS, Ms. 

VELA ́ZQUEZ, and Mr. EVANS) submitted the following resolution; which 

was referred to the Committee on Small Business 

RESOLUTION 

Supporting the goals and ideals of ‘‘National Veterans Small 

Business Week’’. 

Whereas the Armed Forces of the United States trains individuals with the skills, discipline, and leadership necessary to establish and operate a successful business; 

Whereas there are over 1,900,000 businesses owned by veterans in the United States, employing over 5,000,000 individuals; 

Whereas businesses owned by veterans make up 5.9 percent 

of all businesses in the United States; 

Whereas veterans account for more than $1,300,000,000 in 

business every year; 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HRES 824 IH 

Whereas business ownership since 2012 by women veterans 

has increased significantly to over 165,000 businesses; 

Whereas the Small Business Administration serves thousands 

of veterans, service-disabled veterans, women veterans, 

and military spouses annually; 

Whereas the Small Business Administration will be hosting 

events honoring ‘‘National Veterans Small Business 

Week’’ from October 30 through November 3, 2023; 

Whereas Congress and the Small Business Administration 

will be celebrating ‘‘National Veterans Small Business 

Week’’ during the week of October 30 through November 

3, 2023; and 

Whereas the week of October 30 through November 3, 2023, 

would be an appropriate time to celebrate ‘‘National Veterans Small Business Week’’: Now, therefore, be it 

1 Resolved, That the House of Representatives joins 

2 with the Small Business Administration in— 

3 (1) supporting the goals and ideals of ‘‘National 

4 Veterans Small Business Week’’; 

5 (2) supporting veterans through the Small 

6 Business Administration that funds veteran-owned 

7 small business, trains veterans for entrepreneurship, 

8 and provides veterans with contracting opportunities; 

9 (3) celebrating the millions of people in the 

10 United States, especially the veterans of the United 

11 States and the spouses of those veterans, who ben12 efit from the programs of the Small Business Ad13 ministration; and 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HRES 824 IH 

1 (4) expressing appreciation for the continued 

2 service to the United States by the veterans of the 

3 United States through small business ownership and 

4 entrepreneurship. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
```

[Federal Register Volume 78, Number 22 (Friday, February 1, 2013)]
[Notices]
[Page 7415]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02292]

=======================================================================
-----------------------------------------------------------------------

CORPORATION FOR NATIONAL AND COMMUNITY SERVICE

Sunshine Act Notice

    The Board of Directors of the Corporation for National and 
Community Service gives notice of the following meeting:

DATE AND TIME: Wednesday, February 6, 2013, 9:30-11:00 a.m.

PLACE: Time Warner Inc., One Time Warner Center, 10th Floor Conference 
Center, New York, NY 10019-8016. (Entrance on 58th Street between 8th 
and 9th Avenues.)

CALL-IN INFORMATION: This meeting is available to the public through 
the following toll-free call-in number: 888-323-2711 conference call 
access code number 8542. Any interested member of the public may call 
this number and listen to the meeting. Callers can expect to incur 
charges for calls they initiate over wireless lines, and CNCS will not 
refund any incurred charges. Callers will incur no charge for calls 
they initiate over land-line connections to the toll-free telephone 
number. Replays are generally available one hour after a call ends. The 
toll-free phone number for the replay is 888-568-0896, replay passcode 
5990. The end replay date is February 13, 2013, 10:59 p.m. (CT).

STATUS: Open.

MATTERS TO BE CONSIDERED: 
I. Chair's Opening Comments
    a. Call to Order, Welcome, and Preview of Today's Meeting Agenda
    b. Introduction and Acknowledgements
    c. Summary of Retreat
II. Committee Reports
III. Consideration of Previous Meeting's Minutes
IV. CEO Report
V. Acknowledgement of Past Members and Alumni Involvement
VI. Discussions, Deliberations and Official Actions
VII. Public Comments
VIII. Final Comments and Adjournment

    Members of the public who would like to comment on the business of 
the Board may do so in writing or in person. Individuals may submit 
written comments to jmauk@cns.gov subject line: FEBRUARY 2013 CNCS 
BOARD MEETING by 4:00 p.m. ET on Friday February 1st. Individuals 
attending the meeting in person who would like to comment will be asked 
to sign-in upon arrival. Comments are requested to be limited to 2 
minutes.

REASONABLE ACCOMMODATIONS: The Corporation for National and Community 
Service provides reasonable accommodations to individuals with 
disabilities where appropriate. Anyone who needs an interpreter or 
other accommodation should notify Ida Green at igreen@cns.gov or 202-
606-6861 by 5 p.m. on February 1, 2013.

CONTACT PERSON FOR MORE INFORMATION: Jenny Mauk, Special Assistant to 
the CEO, Corporation for National and Community Service, 1201 New York 
Avenue NW., Washington, DC 20525. Phone: (202) 606-6615. Fax: (202) 
606-3460. TTY: (800) 833-3722. Email: jmauk@cns.gov.

    Dated: January 29, 2013.
Valerie Green,
General Counsel.
[FR Doc. 2013-02292 Filed 1-30-13; 11:15 am]
BILLING CODE 6050-$$-P
```
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In  connection  with the  Annual  Report of LORAN CONNECTION CORP(the "Company")  on Form 10-K/A for the period  ended  March 31,  2010 as filed with the Securities  and  Exchange  Commission  on the date  hereof (the  "Report"),  the undersigned,  in the  capacities  and  on  the  dates  indicated  below,  hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:  1.   The Report fully  complies with the  requirements  of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2.   The  information  contained  in the  Report  fairly  presents,  in all material respects,  the financial  condition and results of operations of the Company.  Date: November 15, 2010   /s/ Larysa Dekhtyaruk __________________________ Larysa Dekhtyaruk, President, Chief Executive Officer and Chief Financial Officer
Drew Charles ROSEN, Appellant, v. Elke L. ROSEN, Appellee.

No. 4D16-2819

District Court of Appeal of Florida, Fourth District.

[January 18, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               JUN-30-1996
<CASH>                                       3,374,448
<SECURITIES>                                11,224,769
<RECEIVABLES>                                  881,489
<ALLOWANCES>                                    25,500
<INVENTORY>                                    606,721
<CURRENT-ASSETS>                            16,785,004
<PP&E>                                      12,830,058
<DEPRECIATION>                               3,424,935
<TOTAL-ASSETS>                              26,311,204
<CURRENT-LIABILITIES>                        2,300,366
<BONDS>                                      5,827,827
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    54,036,335
<OTHER-SE>                                   (887,706)
<TOTAL-LIABILITY-AND-EQUITY>                26,311,204
<SALES>                                      3,281,592
<TOTAL-REVENUES>                            12,746,926
<CGS>                                        1,890,573
<TOTAL-COSTS>                                9,826,062
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              91,094
<INCOME-PRETAX>                              3,380,827
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          3,380,827
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 3,380,827
<EPS-PRIMARY>                                      .33
<EPS-DILUTED>                                      .33
        

</TABLE>
**EXHIBIT 32.1**

 

**CHIEF EXECUTIVE OFFICER**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code), I, Robert M. Garst, Chief Executive Officer of Riverview Financial Corporation (the “Company”), hereby certify that, to the best of my knowledge, the Company’s Annual Report on Form 10-K for the period ended December 31, 2010 (the “Report”):

 

1.                                       fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.                                       the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the year ended December 31, 2010.

 

 
| Date:  | March 29,   2011 |   | By:                       | /s/   Robert M. Garst |
|--------|-----------------------|--------|---------------------------|-----------------------|
|   |                  |   | Robert   M. Garst         |
|   |                  |   | Chief   Executive Officer |

 

----
Steve AUSTIN, Jr., Appellant, v. The STATE of Florida, Appellee.

No. 3D17-2002

District Court of Appeal of Florida, Third District.

Opinion filed October 18, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
H. Res. 78 

In the House of Representatives, U. S., 

January 31, 2023. 

Resolved, 

SECTION 1. TOTAL NUMBER OF MEMBERS OF CERTAIN SELECT 

COMMITTEES AND SUBCOMMITTEES. 

(a) PERMANENT SELECT COMMITTEE ON INTELLIGENCE.—Clause 11(a)(1) of rule X of the Rules of the 

House of Representatives is amended by striking ‘‘not more 

than 22 Members, Delegates, or the Resident Commissioner, 

of whom not more than 13 may be from the same party’’ and 

inserting ‘‘not more than 25 Members, Delegates, or the 

Resident Commissioner, of whom not more than 14 may be 

from the same party’’. 

(b) SELECT COMMITTEE ON THE STRATEGIC COMPETITION BETWEEN THE UNITED STATES AND THE CHINESE

COMMUNIST PARTY.—Section 1(a)(2)(A) of House Resolution 11, as agreed to January 10, 2023, is amended by striking ‘‘composed of not more than 16 Members, Delegates, or 

the Resident Commissioner appointed by the Speaker, not 

more than 7 of whom shall be appointed after consultation 
2 

•HRES 78 EH 

with the minority leader’’ and inserting ‘‘composed of not 

more than 24 Members, Delegates, or the Resident Commissioner appointed by the Speaker, not more than 11 of whom 

shall be appointed after consultation with the minority leader’’. 

(c) SELECT SUBCOMMITTEE ON THE WEAPONIZATION

OF THE FEDERAL GOVERNMENT.—Section 1(a)(2)(A) of 

House Resolution 12, as agreed to January 10, 2023, is 

amended by striking ‘‘together with not more than 13 other 

Members, Delegates, or the Resident Commissioner appointed 

by the Speaker, of whom not more than 5 shall be appointed 

in consultation with the minority leader’’ and inserting ‘‘together with not more than 12 other Members, Delegates, or 

the Resident Commissioner appointed by the Speaker, of 

whom not more than 9 shall be appointed in consultation 

with the minority leader’’. 

(d) SELECT SUBCOMMITTEE ON THE CORONAVIRUS

PANDEMIC.—Section 4(a)(1)(B)(i) of House Resolution 5, as 

agreed to January 9, 2023, is amended by striking ‘‘not more 

than 12 Members, Delegates, or the Resident Commissioner 

appointed by the Speaker, of whom not more than 5 shall be 

appointed in consultation with the Minority Leader’’ and inserting ‘‘not more than 16 Members, Delegates, or the Resident Commissioner appointed by the Speaker, of whom not 
3 

•HRES 78 EH 

more than 7 shall be appointed in consultation with the Minority Leader’’. 

Attest: 

Clerk.
[Federal Register Volume 83, Number 1 (Tuesday, January 2, 2018)]
[Notices]
[Page 125]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28256]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-0809]


Issuance of Priority Review Voucher; Rare Pediatric Disease 
Product

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
issuance of a priority review voucher to the sponsor of a rare 
pediatric disease product application. The Federal Food, Drug, and 
Cosmetic Act (FD&C Act), as amended by the Food and Drug Administration 
Safety and Innovation Act (FDASIA), authorizes FDA to award priority 
review vouchers to sponsors of approved rare pediatric disease product 
applications that meet certain criteria. FDA is required to publish 
notice of the award of the priority review voucher. FDA has determined 
that LUXTURNA (voretigene neparvovec), manufactured by Spark 
Therapeutics, Inc., meets the criteria for a priority review voucher.

FOR FURTHER INFORMATION CONTACT: Gretchen Opper, Center for Biologics 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-
402-7911.

SUPPLEMENTARY INFORMATION: FDA is announcing the issuance of a priority 
review voucher to the sponsor of an approved rare pediatric disease 
product application. Under section 529 of the FD&C Act (21 U.S.C. 
360ff), which was added by FDASIA, FDA will award priority review 
vouchers to sponsors of approved rare pediatric disease product 
applications that meet certain criteria upon approval of those 
applications. FDA has determined that LUXTURNA (voretigene neparvovec), 
manufactured by Spark Therapeutics, Inc., meets the criteria for a 
priority review voucher. LUXTURNA (voretigene neparvovec) is an adeno-
associated virus vector-based gene therapy indicated for the treatment 
of patients with confirmed biallelic RPE65 mutation-associated retinal 
dystrophy. Patients must have viable retinal cells as determined by the 
treating physician(s).
    For further information about the Rare Pediatric Disease Priority 
Review Voucher Program and for a link to the full text of section 529 
of the FD&C Act, go to https://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/RarePediatricDiseasePriorityVoucherProgram/default.htm. For further 
information about LUXTURNA (voretigene neparvovec), go to the Center 
for Biologics Evaluation and Research cellular and gene therapy 
products website at https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/default.htm.

    Dated: December 26, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-28256 Filed 12-29-17; 8:45 am]
BILLING CODE 4164-01-P
EXHIBIT 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002








The undersigned, Kaien Liang, the Chief Executive Officer of CHINA EXECUTIVE EDUCATION CORP. (the “Company”), DOES HEREBY CERTIFY that:





1.      The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and





2.      Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.





IN WITNESS WHEREOF, the undersigned has executed this statement this 9th day of November, 2011.








/s/ Kaien Liang


Kaien Liang


Chief Executive Officer


(Principal Executive Officer)








A signed original of this written statement required by Section 906 has been provided to China Executive Education Corp. and will be retained by China Executive Education Corp. and furnished to the Securities and Exchange Commission or its staff upon request.





The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350.  It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




Each of the undersigned hereby certifies, in his capacity as an officer of Alpine Alpha 1, Ltd. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:





(1)           The Annual Report of the Company on Form 10-K for the fiscal year ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated: March 10, 2011





/s/ James Hahn


-------------------------------


James Hahn


Chief Executive Officer and President (principal executive officer) &


Chief Financial Officer (principal financial officer and principal accounting officer)





A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.